Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection (HYPDYN)
|ClinicalTrials.gov Identifier: NCT00905970|
Recruitment Status : Unknown
Verified November 2009 by Germans Trias i Pujol Hospital.
Recruitment status was: Recruiting
First Posted : May 21, 2009
Last Update Posted : July 11, 2011
|Condition or disease|
|Latent Tuberculosis Infection|
|Study Type :||Observational|
|Estimated Enrollment :||105 participants|
|Official Title:||Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection|
|Study Start Date :||May 2009|
|Estimated Primary Completion Date :||December 2011|
|Estimated Study Completion Date :||December 2011|
Patients with LTBI recently diagnosed under prophylactic chemotherapy treatment.
Patients with LTBI recently diagnosed not following any prophylactic chemotherapy treatment.
Patients with LTBI diagnosed time ago.
Positive control for the Exhaled Breath condensate assay only. Patients with active TB will conform this group. The n of this group is determined, as it will only be used as a positive control to prove the bacilli's DNA can be detected in the exhaled breath condensate.
- QuantiFeron-Gold-In Tube method assay [ Time Frame: Every 6 months during 3 years ]
- Detection of M.tuberculosis DNA and RNA in the exhaled breath condensate [ Time Frame: Once every year (every 6 months if possible), during 3 years ]
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00905970
|Contact: Cristina Vilaplana, MDfirstname.lastname@example.org|
|Contact: Pere-Joan Cardona, MD, PhDemail@example.com|
|Fundació Institut Germans Trias i Pujol||Recruiting|
|Badalona, Barcelona, Spain, 08916|
|Sub-Investigator: Cristina Vilaplana, MD|
|Principal Investigator:||Pere-Joan Cardona, MD, PhD||Fundació Institut Germans Trias i Pujol|